All News

In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.

The FDA recently authorized COVID-19 vaccine booster shots for immunocompromised individuals, who comprise about 3% of the US population.

Nicholas Mathews, co-founder of Stillwater Behavioral Health, discusses how pharmacists can respond to the identification of potentially problematic opioid prescription practices at sober-living facilities.

Analyzing how off-target antibodies may be undermining HIV vaccine prototypes allows for design improvements.

Trial is the first to suggest that targeting interleukin-4 and interleukin-13 can help address symptoms such as persistent itching and hives.

When trying determine which drug can be called the most expensive on the market, there are 2 potential answers depending on how you define the question.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

The application is based on overall response data from 90 pooled patients in the KEYNOTE-158 study who received pembrolizumab monotherapy.

Pharmacists can be essential resources for patients seeking advice on the selection and use of nonprescription medications.

CDC publishes a schedule of recommended immunizations, how many doses are required, and at what age they should be administered.

The FDA approved pembrolizumab plus lenvatinib for the first-line treatment of adult patients with advanced RCC.

In the latest Student Cafe interview series, students from the University of Texas at Austin College of Pharmacy discussed the future of pharmacy after the COVID-19 pandemic.

Pharmacists are in a strong position to identify the early warning signs of diabetes because they are often the most accessible and frequently visited members of the health care team.

New potential medications may continue to expand the role of targeted agents.

Patients with microsatellite stable (MSS) colorectal cancer, which represents 95% of all metastatic colorectal cancer cases, are more responsive to checkpoint blockade immunotherapy if the patient’s tumors have not spread to the liver.

Pharmacists can advocate for teen vaccination by providing informational sessions at local high schools as well as through social media platforms.

The investigators found that antibodies generated by a single dose of the Pfizer-BioNTech vaccine was less effective at neutralizing variants of concern, but the second dose dramatically increased responses to virus variants.

The FDA is expected to recommend that individuals with compromised immune systems receive a booster shot of either the Pfizer or Moderna COVID-19 vaccine.

Both asthma and chronic obstructive pulmonary disease cause swelling in the airways that makes it difficult to breathe.

Antonio Ciaccia, CEO of 46brooklyn Research, discusses his company’s efforts to uncover and understand the structure that underlies US drug pricing distortions.

On August 4, 2021, the Biden administration expanded the authority of pharmacy technicians under the PREP Act to allow pharmacy technicians to administer adult flu vaccines during the 2021-2022 flu season.

The CDC now recommends COVID-19 vaccination for all individuals 12 years and older in the United States, including those who are pregnant or breastfeeding.

Sharon Park, PharmD, MEd, BCPS, , associate professor and assistant dean for academic affairs at the Notre Dame of Maryland University School of Pharmacy, discusses career options for pharmacy students outside of the traditional roles of a pharmacist.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, assistant professor of pharmacy practice at Loma Linda University School of Pharmacy, discusses the importance of Black pharmacists in creating equitable access to COVID-19 vaccinations.

The introduction of a biosimilar insulin could result in major shifts in the accessibility and affordability of insulin for all patients.

If approved, pembrolizumab would be the first adjuvant immunotherapy option for this patient population with renal cell carcinoma.

The safety of atezolizumab in the Impower010 trial was consistent with its known safety profile and no new safety signals were identified.

Among those who had hypertension, diabetes, and/or obesity as well as COVID-19, the risk rose to 160%.